Relapsed and/or refractory multiple myeloma: positive CHMP opinion for Farydak
The CHMP ( Committee for Medicinal Products for Human Use ) has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Farydak, intended for the t ...
read article